ERBB2 and cancer: RC48 is a human epidermal growth factor 2-ADC (HER2-ADC) consisting of Hertuzumab, olestatin derivatives and a cleavable linker.130 The ADC targets HER2 antigens on cancer cells with high specificity and enters cells through clathrin and caverin internalization.